DTU Chemistry
This role involves developing next-generation, highly selective inhibitors for fungal receptors using generative AI and computational structural biology methods. The position focuses on leading the computational design cycle, from target analysis to candidate generation and experimental validation, to expand the antifungal drug-development toolbox. It offers a platform for building an independent research profile at the interface of AI, protein engineering, and translational biotechnology.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for DTU Chemistry.
DTU Chemistry didn’t post a salary, so this is our estimate from similar listings.